Featuring Junko Takeshita, MD, PhD, MSCE - University of Pennsylvania
Special Lecture by Peerview Institute for Medical Education
1:00-2:00 - Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Non-Biologic Oral Therapeutic Option - Andrew Blauvelt, MD, MBA - President, Oregon Medical Research Center [ Slide Presentation | CME Information ]
Learning Objectives
- Explain the role of the JAK/STAT signaling pathway in the pathophysiology of psoriasis
- Summarize efficacy and safety data related to current and emerging kinase inhibitors for the treatment of psoriasis
- Treat moderate to severe psoriasis in accordance with current evidence and guidelines, recognizing the role of non-biologic therapies in addressing the burden of disease and comorbidities in individual patients
Start of Official ODS Meeting
2:00-3:00 - Biologics overload! How to choose the right treatment for your psoriasis patient - Junko Takeshita, MD, PhD, MSCE
3:00-4:00 - Patient Case Discussion (Register a case at https://codederm.ohsu.edu)
4:00-5:00 - Addressing disparities in dermatology: the example of psoriasis - Junko Takeshita, MD, PhD, MSCE
5:00-5:15 - Resident Lecture - Rachel Dunlap, MD
5:15-5:30 - Resident Lecture - Erika Hagstrom, MD
Register a Patient for Case Discussion
REGISTRATION
- Members: FREE (Login to register)
- Non-Members: $100
